CD19 & FcαR
Loading...Anti-CD19 & FcαR Products
+ Filter
Loading...- anti-CD19 immunotoxin HD37 (scFv)-PE (AGTO-L047E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-Human CD19 Recombinant Antibody (TAB-108CL) (TAB-108CL)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Antibody
- Application: FC, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1611CL-F(E)) (TAB-1611CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody (HPAB-0268-CN) (HPAB-0268-CN)
-
- Species Reactivity: Human, Cynomolgus monkey
- Type: Human IgG1
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody scFv Fragment (HD37) (TAB-1620CL-S(P))
-
- Application: FuncS
- Mouse Anti-CD19 Recombinant Antibody (TAB-1611CL) (TAB-1611CL)
-
- Species Reactivity: Human
- Type: Mouse IgG2a, κ
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody (HPAB-0418LY) (HPAB-0418LY)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human IgG1
- Application: Cyt, BLI, FC, FuncS, ELISA, WB, RIA
- Human Anti-CD19 Recombinant Antibody (HPAB-0419LY) (HPAB-0419LY)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human IgG1
- Application: ELISA, WB, FC, RIA
- Human Anti-CD19 Recombinant Antibody (HPAB-0420LY) (HPAB-0420LY)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human IgG1
- Application: ELISA, WB, FC, RIA
- Mouse Anti-CD19 Recombinant Antibody (HPAB-0269-CN) (HPAB-0269-CN)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody (HPAB-0270-CN) (HPAB-0270-CN)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: Cyt, FuncS, FC
- Human Anti-CD19 Recombinant Antibody (TAB-1626CL) (TAB-1626CL)
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD19 Recombinant Antibody (TAB-1627CL) (TAB-1627CL)
-
- Type: Fully human antibody
- Application: Depletion
- Anti-Human CD19 Recombinant Antibody (cHD37) (TAB-1621CL)
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: ADCC, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, IF, FC
- Human Anti-CD19 Recombinant Antibody (TAB-1612CL) (TAB-1612CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1613CL) (TAB-1613CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1
- Application: Cyt, FC, FuncS, Inhib
- Human Anti-CD19 Recombinant Antibody (TAB-1614CL) (TAB-1614CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1616CL) (TAB-1616CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody (TAB-1617CL) (TAB-1617CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody (TAB-1618CL) (TAB-1618CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody (TAB-1619CL) (TAB-1619CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Anti-Human CD19 Recombinant Antibody scFv Fragment (cHD37) (TAB-1621CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: FuncS
- Anti-Human CD19 Recombinant Antibody scFv Fragment (396) (TAB-1625CL-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: Depletion, ELISA
- Mouse Anti-CD19 Antibody (clone PGC3D6H10), mRNA (HPAB-0696LY-mRNA)
-
- Species Reactivity: Human
- Mouse Anti-CD19 Recombinant Antibody (clone ME-CD20) (MOB-0278MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: IHC
- Human Anti-CD19 Recombinant Antibody (HPAB-0264-CN) (HPAB-0264-CN)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody (HPAB-0265-CN) (HPAB-0265-CN)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody (HPAB-0266-CN) (HPAB-0266-CN)
-
- Derivation: Humanized
- Species Reactivity: Human, Cynomolgus monkey
- Type: Humanized IgG
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody (HPAB-0267-CN) (HPAB-0267-CN)
-
- Derivation: Humanized
- Species Reactivity: Human, Cynomolgus monkey
- Type: Humanized IgG
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1612CL-S(P)) (TAB-1612CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1613CL-S(P)) (TAB-1613CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1614CL-S(P)) (TAB-1614CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1616CL-S(P)) (TAB-1616CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1617CL-S(P)) (TAB-1617CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1618CL-S(P)) (TAB-1618CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1619CL-S(P)) (TAB-1619CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1612CL-F(E)) (TAB-1612CL-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1613CL-F(E)) (TAB-1613CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1614CL-F(E)) (TAB-1614CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1616CL-F(E)) (TAB-1616CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1617CL-F(E)) (TAB-1617CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1618CL-F(E)) (TAB-1618CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, FC, ICC, IF, FuncS
- Anti-Human CD19 Recombinant Antibody (396) (TAB-1625CL)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: Depletion, ELISA
- Human Anti-CD19 Recombinant Antibody Fab Fragment (TAB-1626CL-F(E)) (TAB-1626CL-F(E))
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD19 Recombinant Antibody Fab Fragment (TAB-1627CL-F(E)) (TAB-1627CL-F(E))
-
- Type: Fully human antibody
- Application: Depletion
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, WB
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Anti-CD19 immunotoxin HD37 (IgG)-PE (AGTO-G076E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-DT (AGTO-G076D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-RTA (AGTO-G076R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-Sap (AGTO-G076S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-DT (AGTO-L047D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD19 immunotoxin HD37 (IgG)-PAP (AGTO-G076P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-RTA (AGTO-L047R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-Sap (AGTO-L047S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-PAP (AGTO-L047P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Mouse Anti-CD19 Recombinant Antibody (TAB-1622CL) (TAB-1622CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody (TAB-1623CL) (TAB-1623CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody (381) (TAB-1624CL)
-
- Application: FC, Inhib, ELISA
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0264-CN-F(E)) (HPAB-0264-CN-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0265-CN-F(E)) (HPAB-0265-CN-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0266-CN-F(E)) (HPAB-0266-CN-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human, Cynomolgus monkey
- Type: Humanized Fab
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0267-CN-F(E)) (HPAB-0267-CN-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human, Cynomolgus monkey
- Type: Humanized Fab
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0268-CN-F(E)) (HPAB-0268-CN-F(E))
-
- Species Reactivity: Human, Cynomolgus monkey
- Type: Human Fab
- Application: ELISA, FC
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0269-CN-F(E)) (HPAB-0269-CN-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0270-CN-F(E)) (HPAB-0270-CN-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: FC
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1622CL-S(P)) (TAB-1622CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1623CL-S(P)) (TAB-1623CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody scFv Fragment (381) (TAB-1624CL-S(P))
-
- Application: FC, Inhib, ELISA
- Anti-Human CD19 Recombinant Antibody (HD37) (TAB-1620CL)
-
- Application: FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1611CL-S(P)) (TAB-1611CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody (clone PGC3D6H10); scfv Fragment (HPAB-0696LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, WB, FC, IF
- Anti-CD19 (huB4)-SPDB-DM4 ADC (ADC-020LCT)
-
- Target: CD19
- Linker: SPDB (N-succinimidyl 4-(2-pyridyldithio)butyrate)
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
-
- Host Species: Human
- Specificity: Human
- Type: Humanized antibody
- Classification: Fc glycosylation/Non fucosylated
- Glycosylation site: Asn297 in Fc region
-
- Host Species: Human
- Specificity: Human
- Type: Humanized antibody
- Classification: Fc glycosylation/Non fucosylated
- Glycosylation site: Asn297 in Fc region
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, ICC, IF, IHC-P, FC
- Anti-Rat CD19 Immunohistochemistry Kit (VS-0525-XY1127)
-
- Species Reactivity: Rat
- Target: CD19
- Application: IHC
- Anti-Mouse CD19 Immunohistochemistry Kit (VS-0525-XY1128)
-
- Species Reactivity: Mouse
- Target: CD19
- Application: IHC
- Anti-CD19 (clone B496)-mc-vc-PABC-MMAE ADC (ADC-183LZY)
-
- Target: CD19
- Linker: mc-VC-PABC (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD19 (clone B496)-mc-MMAF ADC (ADC-184LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
-
- Target: CD19
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: pyrrolobenzodiazepine (PBD) dimers SGD-1882
-
- Targets: CD19 & FcαR
- Type: F(ab')2
- Application: FuncS, Promising therapeutic agent
-
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Classification: Fc glycosylation/Low fucosylated
- Glycosylation site: Asn297 in Fc region
- Glycoform (ratio): GN-GN-M-(M-GN)2
-
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Classification: Fc glycosylation/Low fucosylated
- Glycosylation site: Asn297 in Fc region
- Glycoform (ratio): GN-GN-M-(M-GN)2
-
- Host Species: Mouse
- Specificity: Human
- Type: Mouse antibody
- Classification: Fc glycosylation
- Glycosylation site: Fc region
- Glycoform (ratio): G2-NANA
- Anti-CD19 (clone hBU12)-vcPAB-MMAE ADC (ADC-150CL)
-
- Target: CD19
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (clone BU12)-MC-MMAF ADC (ADC-189CL)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (hBU12)-mcMMAF ADC (ADC-017LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (hBU12)-Mc-MMAE ADC (ADC-019LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (clone huB4)-mc-MMAF ADC (ADC-045LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (clone B496)-SPP-DM1 ADC (ADC-181LZY)
-
- Target: CD19
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (Denintuzumab)-Mc-MMAF ADC (ADC-175LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (clone B496)-MCC-DM1 ADC (ADC-182LZY)
-
- Target: CD19
- Linker: MCC (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone huB4)-SMCC-DM1 ADC (ADC-157LZY)
-
- Target: CD19
- Linker: SMCC (4-[N-maleimidomethyl] cyclohexane-1 carboxylhydrazide).
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone MDX1435)-vc-duocarmycin ADC (ADC-163LZY)
-
- Target: CD19
- Linker: VC (valine-citrulline)
- Drug: duocarmycin
- Anti-CD19 (hBU12)-Mc-MMAF ADC (SGN-19A) (ADC-L034)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
This gene encodes a member of the immunoglobulin gene superfamily. Expression of this cell surface protein is restricted to B cell lymphocytes. This protein is a reliable marker for pre-B cells but its expression diminishes during terminal B cell differentiation in antibody secreting plasma cells. The protein has two N-terminal extracellular Ig-like domains separated by a non-Ig-like domain, a hydrophobic transmembrane domain, and a large C-terminal cytoplasmic domain. This protein forms a complex with several membrane proteins including complement receptor type 2 (CD21) and tetraspanin (CD81) and this complex reduces the threshold for antigen-initiated B cell activation. Activation of this B-cell antigen receptor complex activates the phosphatidylinositol 3-kinase signalling pathway and the subsequent release of intracellular stores of calcium ions. This protein is a target of chimeric antigen receptor (CAR) T-cells used in the treatment of lymphoblastic leukemia. Mutations in this gene are associated with the disease common variable immunodeficiency 3 (CVID3) which results in a failure of B-cell differentiation and impaired secretion of immunoglobulins. CVID3 is characterized by hypogammaglobulinemia, an inability to mount an antibody response to antigen, and recurrent bacterial infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
This gene is a member of the immunoglobulin gene superfamily and encodes a receptor for the Fc region of IgA. The receptor is a transmembrane glycoprotein present on the surface of myeloid lineage cells such as neutrophils, monocytes, macrophages, and eosinophils, where it mediates immunologic responses to pathogens. It interacts with IgA-opsonized targets and triggers several immunologic defense processes, including phagocytosis, antibody-dependent cell-mediated cytotoxicity, and stimulation of the release of inflammatory mediators. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene.


Primary Immunodeficiency